Literature DB >> 24838279

Fibroblast activation protein, a potential diagnostic and therapeutic target for cancer.

Xiang Lin1, Cheng Huang1, Lingna Kong1, Yong He1, Dexi Zhou1, Jun Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24838279     DOI： 10.1016/j.humpath.2013.11.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  2 in total

Review 1.  The application of the fibroblast activation protein α-targeted immunotherapy strategy.

Authors:  Guan-Min Jiang; Wei Xu; Jun Du; Kun-Shui Zhang; Qiu-Gui Zhang; Xiao-Wei Wang; Zhi-Gang Liu; Shuang-Quan Liu; Wan-Ying Xie; Hui-Fang Liu; Jing-Shi Liu; Bai-Ping Wu
Journal:  Oncotarget       Date:  2016-05-31

2.  Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects.

Authors:  Jae Min Cho; Eun Hee Yang; Wenying Quan; Eun Hye Nam; Hyae Gyeong Cheon
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.